"The study was commissioned in response to last year's Cass review of gender identity services which found that gender medicine was an area of remarkably weak evidence and built on shaky foundations. Originally used to treat early-onset puberty, puberty blockers had been prescribed off-label to children with gender dysphoria until the NHS banned their use last year after the Cass review."
"Legal letters have been issued to the medical regulators responsible for the trial, and copied to the health secretary, Wes Streeting, and NHS England. The action has been launched by campaigners from the Bayswater Support Group, made up of parents of children and young adults who identify as trans or non-binary, along with the psychotherapist James Esses, who treats children with gender dysphoria, and Keira Bell, who began taking puberty blockers as a teenager before later detransitioning."
Campaigners have initiated legal action intended to suspend an NHS-funded clinical trial of puberty blockers on grounds that it could harm participating children. The trial was commissioned after the Cass review, which found gender medicine to have weak evidence and shaky foundations. Puberty blockers were originally for early-onset puberty and were prescribed off-label to children with gender dysphoria until the NHS banned their use following the Cass review. Legal letters were sent to medical regulators and copied to the health secretary and NHS England. The action was launched by the Bayswater Support Group, psychotherapist James Esses, and Keira Bell, who cite potential irreversible fertility damage, limited known benefits of treatment, and advocate counselling as an effective alternative for some children. The NHS England-funded Pathways trial, run by King's College London, plans to recruit about 226 young people aged roughly 10–15 over three years.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]